JP2001509130A - テトラヒドロベータ―カルボリン化合物群 - Google Patents
テトラヒドロベータ―カルボリン化合物群Info
- Publication number
- JP2001509130A JP2001509130A JP53449297A JP53449297A JP2001509130A JP 2001509130 A JP2001509130 A JP 2001509130A JP 53449297 A JP53449297 A JP 53449297A JP 53449297 A JP53449297 A JP 53449297A JP 2001509130 A JP2001509130 A JP 2001509130A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- compound according
- hydrogen
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式I: [ここに R1は水素またはC1−C3アルキルであり; R3は水素またはC1−C3アルキルであり; R6は水素、C1−C6アルキル、C2−C6アルケニル、ハロ、ハロ(C1−C6) アルキル、ハロ(C2−C6)アルケニル、COR5、C1−C10アルカノイル、C O2R5'、(C1−C6アルキル)mアミノ、NO2、−SR5およびOR5からなる 群から選択され; R7およびR8は独立して水素、C1−C6アルキル、C2−C6アルケニル、NO2 、ハロ、ハロ(C1−C6)アルキル、ハロ(C2−C6)アルケニル、COR5、 C1−C10アルカノイル、C7−C16アリールアルキル、CO2R5'、(C1−C6 アルキル)mアミノ、−SR5およびOR5からなる群から選択され; nは1、2または3であり; n’は1、2または3であり; mは1または2であり; R5は独立して水素またはC1−C4アルキルであり; R5'はC1−C4アルキルであり; −−−は結合であることもあることを表す] で示される化合物、製薬的に許容されるその塩または溶媒和物。 2.R1が水素である請求項1に記載の化合物。 3.R3が水素である請求項2に記載の化合物。 4.スピロ置換分がナフチル類似基である請求項3に記載の化合物。 5.スピロ置換分が式: で示される請求項3に記載の化合物。 6.スピロ置換分が式: で示される請求項4に記載の化合物。 7.スピロ置換分が式: で示される請求項3に記載の化合物。 8.−−−が芳香環を形成する二重結合である請求項1に記載の化合物。 9.nが1であり、n’が1である請求項3に記載の化合物。 10.nが2であり、n’が1である請求項3に記載の化合物。 11.nが1または2であり、n’が2である請求項3に記載の化合物。 12.R6がフェニル環の第5位に存在する請求項3に記載の化合物。 13.R6が水素、メチル、クロロおよびブロモからなる群から選択される請求 項12に記載の化合物。 14.R7およびR8が独立してメトキシおよびエトキシからなる群から選択され る請求項13に記載の化合物。 15.R7およびR8が第3位および第4位にある請求項4に記載の化合物。 16.R7およびR8がそれぞれメトキシおよびエトキシからなる群から選択され る請求項4に記載の化合物。 17.化合物がからなる群から選択される請求項1に記載の化合物。 18.請求項1に記載の化合物および1つまたはそれ以上の製薬的に許容される 賦形剤を含む医薬製剤。 19.5HT2B調節に関連する症状を患っているか、あるいは該症状に罹患しや すい哺乳類の処置方法であって、該哺乳類に有効量の請求項1の化合物を投与す ることを特徴とする方法。 20.機能的腸障害を患っているか、あるいは該症状に罹患しやすい哺乳類を処 置するための請求項19に記載の方法。 21.レセプター結合投与量の、5−HT2Bレセプターに選択的に結合する化合 物を、5−HT2Bレセプターへの選択的結合を必要とする哺乳類に投与すること を特徴とする、哺乳類における5−HT2Bレセプターに選択的に結合させる請求 項19に記載の方法。 22.5HT2B調節に関連する症状を患っているか、あるいは該症状に罹患しや すい哺乳類の処置方法であって、請求項1に記載のレセプター結合投与量の5H T2B結合化合物を投与することを特徴とする方法。 23.5HT2B調節に関連する症状を患っているか、あるいは該症状に罹患しや すい哺乳類の処置において用いるための請求項1に記載の化合物。 24.5−HT2Bレセプターへの選択的結合に用いるための請求項1に記載の化 合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1411996P | 1996-03-25 | 1996-03-25 | |
US60/014,119 | 1996-03-25 | ||
PCT/US1997/004473 WO1997035578A1 (en) | 1996-03-25 | 1997-03-24 | Tetrahydro-beta-carboline compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001509130A true JP2001509130A (ja) | 2001-07-10 |
JP2001509130A5 JP2001509130A5 (ja) | 2004-11-25 |
Family
ID=21763645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53449297A Ceased JP2001509130A (ja) | 1996-03-25 | 1997-03-24 | テトラヒドロベータ―カルボリン化合物群 |
Country Status (20)
Country | Link |
---|---|
US (1) | US5886004A (ja) |
EP (1) | EP0942722B1 (ja) |
JP (1) | JP2001509130A (ja) |
KR (1) | KR20000004963A (ja) |
CN (1) | CN1225584A (ja) |
AT (1) | ATE267012T1 (ja) |
AU (1) | AU714024B2 (ja) |
BR (1) | BR9708347A (ja) |
CA (1) | CA2248874A1 (ja) |
CZ (1) | CZ298098A3 (ja) |
DE (1) | DE69729211T2 (ja) |
EA (1) | EA199800867A1 (ja) |
ES (1) | ES2221049T3 (ja) |
IL (1) | IL126062A0 (ja) |
NO (1) | NO984445L (ja) |
NZ (1) | NZ331827A (ja) |
PL (1) | PL329212A1 (ja) |
TR (1) | TR199801910T2 (ja) |
WO (1) | WO1997035578A1 (ja) |
YU (1) | YU41998A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006508114A (ja) * | 2002-11-11 | 2006-03-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | スピロ環状シクロヘキサン誘導体 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5886003A (en) * | 1996-03-25 | 1999-03-23 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of venomous bites and stings |
ES2152860B1 (es) * | 1998-10-23 | 2001-08-16 | Finaf 92 Sa | Forma cristalina de la nefazodona y procedimiento para su preparacion. |
WO2000069437A1 (en) | 1999-05-18 | 2000-11-23 | Synaptic Pharmaceutical Corporation | Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder |
US6444477B1 (en) * | 2000-11-28 | 2002-09-03 | Pharmagene Laboratories Limited | Assay method for detecting 5-HT2B antagonists |
EP1716867A4 (en) * | 2004-02-20 | 2009-09-23 | Astellas Pharma Inc | PRENENT AGENTS FOR MIGRAINE |
US7550499B2 (en) * | 2004-05-12 | 2009-06-23 | Bristol-Myers Squibb Company | Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
MX2007008434A (es) * | 2005-01-19 | 2007-07-25 | Squibb Bristol Myers Co | Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos. |
WO2006085510A1 (ja) * | 2005-02-08 | 2006-08-17 | Astellas Pharma Inc. | 過敏性腸症候群の治療薬 |
DE602006017694D1 (de) * | 2005-06-27 | 2010-12-02 | Bristol Myers Squibb Co | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden |
AU2006261828A1 (en) * | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
EP1896417B1 (en) | 2005-06-27 | 2011-03-23 | Bristol-Myers Squibb Company | Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
WO2007002634A1 (en) * | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
CA2617473A1 (en) * | 2005-08-08 | 2007-02-15 | Astellas Pharma Inc. | Acylguanidine derivative or salt thereof |
US7960569B2 (en) * | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
WO2012051502A1 (en) | 2010-10-14 | 2012-04-19 | University Of Utah Research Foundation | Methods and compositions related to neuroactive thiazoline compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5500431A (en) * | 1993-04-14 | 1996-03-19 | Eli Lilly And Company | Tetrahydro-β-carbolines |
CA2185236A1 (en) * | 1994-03-11 | 1995-09-14 | James Edmund Audia | Method for treating 5ht2b receptor related conditions |
US5663178A (en) * | 1995-02-06 | 1997-09-02 | Eli Lilly And Company | Tetrahydro-beta carbolines |
JP2000507269A (ja) * | 1996-03-15 | 2000-06-13 | イーライ・リリー・アンド・カンパニー | 一般かぜまたはアレルギー性鼻炎の処置方法 |
US5886003A (en) * | 1996-03-25 | 1999-03-23 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of venomous bites and stings |
-
1997
- 1997-03-24 BR BR9708347A patent/BR9708347A/pt not_active Application Discontinuation
- 1997-03-24 EA EA199800867A patent/EA199800867A1/ru unknown
- 1997-03-24 CA CA002248874A patent/CA2248874A1/en not_active Abandoned
- 1997-03-24 JP JP53449297A patent/JP2001509130A/ja not_active Ceased
- 1997-03-24 WO PCT/US1997/004473 patent/WO1997035578A1/en active IP Right Grant
- 1997-03-24 PL PL97329212A patent/PL329212A1/xx unknown
- 1997-03-24 ES ES97916854T patent/ES2221049T3/es not_active Expired - Lifetime
- 1997-03-24 EP EP97916854A patent/EP0942722B1/en not_active Expired - Lifetime
- 1997-03-24 CZ CZ982980A patent/CZ298098A3/cs unknown
- 1997-03-24 US US08/823,456 patent/US5886004A/en not_active Expired - Fee Related
- 1997-03-24 DE DE69729211T patent/DE69729211T2/de not_active Expired - Fee Related
- 1997-03-24 AU AU25361/97A patent/AU714024B2/en not_active Ceased
- 1997-03-24 CN CN97194732A patent/CN1225584A/zh active Pending
- 1997-03-24 KR KR1019980707567A patent/KR20000004963A/ko not_active Application Discontinuation
- 1997-03-24 TR TR1998/01910T patent/TR199801910T2/xx unknown
- 1997-03-24 AT AT97916854T patent/ATE267012T1/de not_active IP Right Cessation
- 1997-03-24 IL IL12606297A patent/IL126062A0/xx unknown
- 1997-03-24 NZ NZ331827A patent/NZ331827A/en unknown
-
1998
- 1998-09-24 NO NO984445A patent/NO984445L/no unknown
- 1998-09-25 YU YU41998A patent/YU41998A/sh unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006508114A (ja) * | 2002-11-11 | 2006-03-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | スピロ環状シクロヘキサン誘導体 |
JP2010270155A (ja) * | 2002-11-11 | 2010-12-02 | Gruenenthal Gmbh | スピロ環状シクロヘキサン誘導体 |
JP4728645B2 (ja) * | 2002-11-11 | 2011-07-20 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | スピロ環状シクロヘキサン誘導体 |
Also Published As
Publication number | Publication date |
---|---|
EP0942722A4 (en) | 2002-06-05 |
US5886004A (en) | 1999-03-23 |
CN1225584A (zh) | 1999-08-11 |
DE69729211D1 (en) | 2004-06-24 |
AU714024B2 (en) | 1999-12-16 |
NO984445L (no) | 1998-11-20 |
PL329212A1 (en) | 1999-03-15 |
DE69729211T2 (de) | 2005-05-04 |
EA199800867A1 (ru) | 1999-02-25 |
IL126062A0 (en) | 1999-05-09 |
EP0942722B1 (en) | 2004-05-19 |
KR20000004963A (ko) | 2000-01-25 |
BR9708347A (pt) | 1999-08-03 |
ES2221049T3 (es) | 2004-12-16 |
NZ331827A (en) | 2000-02-28 |
TR199801910T2 (xx) | 1998-12-21 |
WO1997035578A1 (en) | 1997-10-02 |
ATE267012T1 (de) | 2004-06-15 |
NO984445D0 (no) | 1998-09-24 |
CZ298098A3 (cs) | 1999-02-17 |
YU41998A (sh) | 1999-07-28 |
CA2248874A1 (en) | 1997-10-02 |
AU2536197A (en) | 1997-10-17 |
EP0942722A1 (en) | 1999-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5760051A (en) | Tetrahydro-beta-carbolines | |
JP2001509130A (ja) | テトラヒドロベータ―カルボリン化合物群 | |
JP3224372B2 (ja) | 複素環式カルボキサミド | |
US6380238B1 (en) | Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands | |
US5643916A (en) | Tetrahydro-beta-carbolines | |
US5488053A (en) | Tetrahydro-pyrido-indole | |
JP2006111553A (ja) | スルホニルオキシインドール誘導体及びそれを含有する医薬組成物 | |
JPH09501429A (ja) | 選択的ドーパミンd3リガンドとしての2−アミノインダン類 | |
US4894386A (en) | Aliphatic carboxamides | |
SK12012003A3 (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
US5631265A (en) | 8-substituted tetrahydro-beta-carbolines | |
US5861409A (en) | Tetrahydro-beta-carbolines | |
CA2720275A1 (en) | Indolinone compound | |
US5500431A (en) | Tetrahydro-β-carbolines | |
JP2010516795A (ja) | アリール置換スルホンアミド | |
JP2653382B2 (ja) | 3―スルホニル―3,7―ジアザビシクロ〔3,3,1〕1ナン―化合物,その製法及びこれを含有する胃の運動機能障害治療用薬剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040206 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071225 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080527 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080708 |